Injecting drug use IDU

Documents

Asia and the Pacific regional profile — 2024 global AIDS update The Urgency of Now: AIDS at a Crossroads

22 July 2024

In 2023, 6.7 million [6.1 million–7.5 million] people living with HIV were residing in Asia and the Pacific, making this the world’s largest epidemic after eastern and southern Africa. The region accounts for a quarter of annual new HIV infections globally (23%). People from key populations and their sex partners are disproportionately affected. Among countries with available data, HIV epidemics are growing in Afghanistan, Bangladesh, Fiji, the Lao People’s Democratic Republic, Papua New Guinea and the Philippines. Between 2010 and 2022, numbers of new HIV infections increased by 32% among gay men and other men who have sex with men and by 85% among non-client sex partners of people from key populations. Related links: New UNAIDS report shows AIDS pandemic can be ended by 2030, but only if leaders boost resources and protect human rights now | Full report

Documents

2024 global AIDS report — The Urgency of Now: AIDS at a Crossroads

22 July 2024

This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome. Related links: Press release | Special web site | Executive summary | Fact sheet | Video playlist | Epidemiology slides | Data on HIV | Annex 2: Methods Regional profiles: Asia and the Pacific | Caribbean | Eastern Europe and Central Asia | Eastern and Southern Africa| Latin America | Middle East and North Africa | Western and Central Africa | Western and Central Europe and North America Thematic briefing notes: People living with HIV | Gay men and other men who have sex with men | Transgender people | Sex workers | People who inject drugs | People in prisons and other closed settings | Adolescent girls and young women | Other translations: German

Documents

56th session of the Human Rights Council

26 June 2024

Remarks by UNAIDS Executive Director at the Breakfast Discussion in the Margin of the 56th session of the Human Rights Council — Geneva, 26 June 2024

Press Release

To help ensure the end of AIDS, leaders need to move away from punitive approaches to people who use drugs

GENEVA, 26 June 2024—UNAIDS welcomes the recent report by Dr Tlaleng Mofokeng, Special Rapporteur on the Highest Attainable Standard of Physical and Mental Health, which was presented to the 56th session of the UN Human Rights Council. The report, on Drug Use, Harm Reduction and the Right to Health, demonstrates the public health necessity of moving away from punitive approaches to people who use drugs.

Notable, in particular, are three recommendations of the Special Rapporteur’s report that are critical to ending AIDS as a public health threat:

  1. Decriminalization of the possession of drugs for personal use.
  2. Ensuring the availability, accessibility, acceptability and quality of harm reduction services for people who use drugs.
  3. Ensuring that peer-led initiatives have the necessary political and policy support and sufficient and stable resourcing.

Currently, many people who inject drugs continue to be left behind by the global HIV response. The risk of acquiring HIV is 14 times higher than it is for the adult population generally. In contrast, countries which have successfully scaled up harm reduction services have seen significant declines in HIV infections among people who use drugs.

Harm reduction services need to be accessible and acceptable to all who use them. Currently, whilst women who use drugs have a higher prevalence of HIV than men who use drugs, harm reduction services are still often not designed with women’s particular requirements in mind. As the Special Rapporteur on the Right to Health’s report recommends to states: “Design harm reduction services so that they provide suitable environments for women who use drugs, including by providing integrated sexual and reproductive health care, information and services, and childcare”.

Law reform is essential because the evidence shows that even when services are available and appropriate, punitive laws obstruct their use. Criminalization of drug use is associated with needle sharing and avoidance of harm reduction programmes, and increased risk of HIV.

Community leadership in programme design is vital for programme effectiveness. As UNAIDS Executive Director Winnie Byanyima noted today at the special side event with Dr Tlaleng Mofokeng: “Barriers to accessing services can only be overcome if the communities living with, affected by and vulnerable to HIV are supported to lead. This includes communities of people who use drugs, sex workers, gay men and other men who have sex with men, transgender people and people living with HIV. We will continue to leave people behind if we do not support communities in the lead in both service delivery and law reform.”

Global and national approaches to drug policies are starting to change, and this excellent report by the UN Special Rapporteur on the Right to Health will help accelerate this small but important and growing wave of changes. As this report notes, the FRESH project, for example, is engaging transgender women in harm reduction programming, with UNAIDS support. Kenya is one of the countries which has scaled up services, and currently has more than 10 public opioid agonist therapy programmes and 35 drop-in centres with needle-syringe programmes, as well as take-home naloxone, pre-exposure prophylaxis and HIV self-testing services. This year, the Commission on Narcotic Drugs adopted, for the first time, a resolution recognizing the need for harm reduction.

Punitive approaches have hurt public health, including the HIV response. Evidence-based approaches will help enable the world to end AIDS as a public health threat by 2030. UNAIDS pays tribute to Dr Tlaleng Mofokeng, and stands with communities as they issue a call to leaders worldwide: “Support, don’t punish”.

UNAIDS

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube.

Remarks by UNAIDS Executive Director

Documents

The BBS-lite: A methodology for monitoring programmes providing HIV, viral hepatitis and sexual health services to people from key populations — UNAIDS–WHO 2024 Implementation Tool

22 May 2024

The BBS-lite (bio-behavioural survey “lite”) is a programme-based survey methodology for gathering actionable information on people from key populations to improve service delivery and guide decisions on programming for HIV, viral hepatitis and sexually transmitted infections.

Documents

New HIV infections data among key populations: proportions in 2010 and 2022

25 March 2024

The context of the HIV epidemics and total adult infection trends differ notably between sub-Saharan Africa and elsewhere. In sub-Saharan Africa, overall, the number of adult infections among people 15–49 years old fell markedly between 2010 to 2022, from 1.1 million to 510000 (54% decline). However, the rest of the world has not seen declines in new HIV infections among adults between 2010 and 2022, which stood at 580 000 in both years (1% increase using unrounded numbers).

Press Statement

UNAIDS welcomes the adoption of a crucial resolution recognizing harm reduction measures at the UN Commission on Narcotic Drugs

VIENNA/GENEVA, 22 March 2024— UNAIDS welcomes the adoption of a key resolution today at the 67th session of the United Nations Commission on Narcotic Drugs (CND), recognizing harm reduction for the first time as an important part of an effective public health response. The resolution encourages member states to develop and implement harm reduction measures to minimize the adverse public health and social consequences of the non-medical use of illicit drugs. UNAIDS congratulates the CND and the CND Chair for this historic milestone.

The resolution represents a landmark in political commitment to a rebalancing of drug policy towards a public health approach. Such a shift is critical to meeting the targets in the 2021-2026 Global AIDS Strategy.

Harm reduction is a “a comprehensive package of evidence-based interventions, based on public health and human rights, including needle syringe programmes (NSPs), opioid agonist maintenance therapy (OAMT) and naloxone for overdose management. Harm reduction also refers to policies and strategies that aim to prevent major public and individual health harms, including HIV, viral hepatitis and overdose, without necessarily stopping drug use.” (World Health Organization, 2022).

Since 2018 only five countries have reported achieving the target of providing 200 sterile needles and syringes per person who inject drugs. In that same timeframe only three countries reported achieving the target of 50% coverage of opioid agonist maintenance therapy among people who inject drugs.

The criminalization of drug use and possession for personal use in at least 145 countries, along with stigma, discrimination and violence, continues to restrict both the provision of and access to life-saving harm reduction services.

A failure to invest in harm reduction services or remove the structures that inhibit access, including those relating to gender, have led to a situation where HIV prevalence among people who inject drugs is 7 times that of the rest of the population, and people who inject drugs have the highest incidence globally of any key or vulnerable population. In countries with data, median HIV prevalence among women who inject drugs is almost twice that of men who use drugs.

Under the UN Common Position on Drugs, UNAIDS collaborates with other UN agencies and partners with governments, community-led organizations and donors to increase the provision of harm reduction services and remove harmful laws and policies which create barriers to accessing such services, such as the criminalization of possession of drugs for personal use. UNAIDS works to ensure all efforts relating to drug policy are in conformity with international human rights, as outlined in the international guidelines on human rights and drug policy.

UNAIDS

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube.

Contact

UNAIDS Geneva
Michael Hollingdale
tel. +41 79 500 2119
hollingdalem@unaids.org

Related: UNAIDS urges scaling up of evidence-based services to address the transmission of HIV and viral hepatitis among people who use drugs

Press Statement

UNAIDS urges scaling up of evidence-based services to address the transmission of HIV and viral hepatitis among people who use drugs

VIENNA/GENEVA,14 March 2024—At the 67th meeting of the United Nations Commission on Narcotic Drugs taking place in Vienna, UNAIDS has called for the urgent scaling up of services to prevent new HIV and viral hepatitis infections among people who use drugs. Addressing delegates in her video message, UNAIDS Executive Director, Winnie Byanyima, commended some countries for making progress in implementing evidence-based programmes but called for bolder action.

“Gathered here are leaders whose decisions can save and transform lives, tackle social exclusion, and protect public health for everyone. As leaders you can deliver on the shared pledge to end AIDS as a public health threat by 2030 – if all people can secure the HIV prevention, testing, treatment and care services they need. To end AIDS we need to ensure that no one is excluded,” said Ms Byanyima.

Since the 2019 Ministerial Declaration of the United Nations Commission on Narcotic Drugs (CND) there has been some progress in a rebalancing of drug policy towards public health. Several countries have moved towards a more public health-based approach to drug use, with some, such as Ghana, decriminalizing all personal drug use. UNAIDS is supporting Brazil in engaging transgender women in harm reduction programming.

The context of the COVID-19 response led some countries to increase the availability of take-home doses of opioid agonist maintenance therapy, such as in Vietnam. Communities have been central to progress in programmes and policy reforms; in Kenya, Tanzania and Uganda peer groups have been instrumental in delivering harm reduction interventions, law enforcement training sessions and awareness-raising initiatives, including women-centred harm reduction services in Kenya.

But progress remains piecemeal. Services such as needle-syringe programmes, and opioid agonist maintenance therapy, crucial for reducing HIV and other health risks among people who inject drugs, only exist in around 50% of countries. In 2019, UNAIDS reported that only 1% of people who inject drugs had access to recommended harm reduction services, and since then no additional country has reported achieving recommended levels of coverage.

Too often, laws and policies continue to exacerbate exclusion, and people who use drugs are today seven times more likely to be living with HIV than other adults. Drug possession for personal use is still criminalized in 145 countries – with 34 countries retaining the death penalty. The stigma, and outright fear, that this exacerbates is driving people away from vital health services.

Attending the meeting in Vienna, UNAIDS Deputy Executive Director, Christine Stegling said:

“We know that drug prohibition has failed. Punitive drug laws and law enforcement practices create significant barriers for people who inject drugs to access a range of services, increasing their risk of acquiring HIV and reducing their access to services. To protect public health, we need to decriminalize possession of drugs for personal use, we need to significantly scale up harm reduction service provision, and we need to make sure that communities of people who use drugs are adequately resourced and in the lead in the response.” 

UNAIDS

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube.

Contact

UNAIDS Geneva
Michael Hollingdale
tel. +41 79 500 2119
hollingdalem@unaids.org

Remarks by UNAIDS Executive Director

Global AIDS targets 2025 for people who use drugs: Where are we now?

Watch

Documents

Global AIDS targets 2025 for people who use drugs: Where are we now?

11 March 2024

In 2024, five years later, the data show that people who inject drugs are still being left behind in the response. In 2022, the global median HIV prevalence among people who inject drugs was 5% across 50 reporting countries, seven times higher than among the rest of the adult population (aged 15–49 years). This figure hides significant geographical and population-based disparities. Among reporting countries, HIV prevalence ranged from 0% to 51%. Among the 16 countries with gender disaggregated data, the reported median HIV prevalence among men who inject drugs was 9%, while it was nearly double (15%) among women who inject drugs.

Documents

67th Session of the Commission on Narcotic Drugs

14 March 2024

Remarks by UNAIDS Executive Director at the 67th Session of the Commission on Narcotic Drugs — Vienna, 14 March 2024

Subscribe to Injecting drug use IDU